The surface layer protein of Bacillus thuringiensis CTC forms unique intracellular parasporal inclusion body

Journal of Basic Microbiology
Chenguang Zhu, Ziniu Yu

Abstract

Bacillus thuringiensis subsp. finitimus strain CTC forms round parasporal inclusion body. The inclusion body protein gene ctc has been cloned and characterized. Sequence homology analysis reveals that the amino acid sequence of CTC protein shows 87% identity with the surface layer (S-layer) protein Sap (GenBank Z36946) in B. anthracis. In this report, transmission electron microscope observation showed that CTC formed intracellular parasporal inclusion body and sheet structure of S-layer-like protein at the spore phase. Furthermore, the ctc gene was transformed into an acrystalliferous B. thuringiensis strain BMB171. The resulting transformant could form parasporal body which had the same shape and molecular weight of protein with that of B. thuringiensis CTC. These results, together with the sequence homology analysis of ctc gene, confirmed that the unique intracellular parasporal inclusion body of B. thuringiensis was comprised of S-layer protein.

References

Dec 1, 1991·Gene·O Arantes, D Lereclus
Dec 1, 1989·Journal of Bacteriology·M D Luckevich, T J Beveridge
Sep 8, 1998·Microbiology and Molecular Biology Reviews : MMBR·E SchnepfD H Dean
Sep 8, 1998·Microbiology and Molecular Biology Reviews : MMBR·N CrickmoreD H Dean
Apr 23, 1999·Journal of Applied Microbiology·M M LecadetI Thiéry
Jan 29, 2000·Journal of Bacteriology·M Sára, U B Sleytr
Jun 1, 2000·Applied and Environmental Microbiology·E HelgasonA B Kolstø
Jan 5, 2006·Applied and Environmental Microbiology·Guadalupe PeñaAlejandra Bravo
Jan 5, 2006·Canadian Journal of Microbiology·Harald ClausHelmut König
Sep 25, 2007·Journal of Structural Biology·Harald Engelhardt
Nov 3, 2007·Science·Mario SoberónAlejandra Bravo
Nov 6, 2007·Nature Biotechnology·James A BaumJames Roberts

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anthrax

Anthrax toxin, comprising protective antigen, lethal factor, and oedema factor, is the major virulence factor of Bacillus anthracis, an agent that causes high mortality in humans and animals. Here is the latest research on Anthrax.

Anthrax Vaccines

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.

Anthrax Vaccines (ASM)

Three different types of anthrax vaccines are available; a live-attenuated, an alum-precipitated cell-free filtrate and a protein recombinant vaccine. The effectiveness between the three is uncertain, but the live-attenuated have shown to reduce the risk of anthrax with low adverse events. Here is the latest research on anthrax vaccines.